Related Experiment Video
Updated: Sep 16, 2025
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.1K
Roflumilast and the Changing Landscape of Seborrheic Dermatitis Treatment
Jimmy Dhillon1, Aryan Mahajan1, Joy Xie1
1Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
The Annals of Pharmacotherapy
|July 10, 2025
Summary
Roflumilast effectively treats seborrheic dermatitis, showing significant symptom improvement and a favorable safety profile in clinical trials. Further research will compare its efficacy against other available treatments.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Seborrheic dermatitis is a common inflammatory skin condition.
- Phosphodiesterase-4 (PDE4) inhibitors represent a novel therapeutic class.
Purpose of the Study:
- To review clinical trial data on roflumilast for seborrheic dermatitis.
- To assess the safety, efficacy, and clinical utility of roflumilast.
Main Methods:
- Literature review of MEDLINE (PubMed) and ClinicalTrials.gov.
- Inclusion of English articles on roflumilast's safety, efficacy, pharmacodynamics, and pharmacokinetics.
Main Results:
- Roflumilast demonstrated significantly higher Investigator Global Assessment (IGA) success rates compared to vehicle in Phase IIa and III trials (73.8% vs 40.9% and 79.5% vs 58.0%, respectively).
- Statistically significant reductions in erythema, scaling, and itch severity were observed with roflumilast.
- Roflumilast exhibited a well-tolerated safety profile with adverse events comparable to vehicle foam.
Conclusions:
- Roflumilast is an effective treatment for seborrheic dermatitis.
- It offers a positive safety profile and ease of application.
- Future trials are recommended to compare roflumilast with existing therapies.
Related Concept Videos
01:19Antiasthma Drugs: Leukotriene Modifiers
489
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
489
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
208
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
208
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
398
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
398
01:26COPD: Management Using Bronchodilators and Corticosteroids
322
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
322
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
471
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
471
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
275
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
275